NCT00044707View on ClinicalTrials.gov

Evaluation of an Orally Administered Medication When Taken in Conjunction With Pramlintide

PHASE2CompletedINTERVENTIONAL

Enrollment

24

Participants

Timeline

Start Date

August 31, 2002

Primary Completion Date

September 30, 2002

Study Completion Date

September 30, 2002

Conditions

Diabetes Mellitus, Non-Insulin-Dependent

Interventions

DRUG

Pramlintide acetate

Clear, colorless, sterile solution for SC injection.

Trial Locations (1)

33301

ICSL-Clinical Studies, Fort Lauderdale

Sponsors

Lead Sponsor

All Listed Sponsors

lead

AstraZeneca

INDUSTRY